PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2DX22FPSZC4556526241!sodium thiosulfate — Dms Pharmaceutical Group Inc

Dms Pharmaceutical Group Inc holds $737.3M across 100,503 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award under parent SPE2DX15D9901. PoP ended Mar 9, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support
Awarding office
Dms Pharmaceutical Group Inc
Recipient
Mar 9, 2022
PoP end
$668K
Obligated
$668K
Potential
424210
NAICS
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Dms Pharmaceutical Group Inc — $90

Contract facts

Federal
Contract numberSPE2DX22FPSZC
Also listed asSPE2DX15D9901-SPE2DX22FPSZC
AgencyDla Troop Support
Awarding officeDla Troop Support
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentDms Pharmaceutical Group Inc
CAGE1UNB0
UEIPX72BSBQTKJ3
NAICS424210

No full NAICS 424210 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDVSPE2DX15D9901
Place of performancePARK RIDGE IL
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startMar 8, 2022
PoP end (current)Mar 9, 2022
Obligated$668K
Current value$668K
Potential value$668K

4556526241!SODIUM THIOSULFATE is a federal award for Dla Troop Support held by Dms Pharmaceutical Group Inc. Estimated value $668K ($668K obligated). Current period of performance ends Mar 9, 2022. Place of performance: PARK RIDGE IL.

Recompete timing

Public
Past PoP end (1626 days ago)

Current PoP ended Mar 9, 2022 (1626 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Dms Pharmaceutical Group Inc$737.3M obligated across 100,503 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($737.3M) · all agencies
Department of Defense (DOD)$737.1M · 100%Department of Veterans Affairs (VA)$193K · 0%
Open full company profile

Related awards

Same parent · incumbent
SPE2D026F0120
8511978882!OTHER MEDICAL
$248K
Apr 26, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract SPE2DX22FPSZC?

SPE2DX22FPSZC (4556526241!sodium thiosulfate) is a Dla Troop Support award with a potential value of $668K, currently held by Dms Pharmaceutical Group Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded SPE2DX22FPSZC?

Dla Troop Support awarded SPE2DX22FPSZC to Dms Pharmaceutical Group Inc (potential $668K).

Who is the incumbent on SPE2DX22FPSZC?

Dms Pharmaceutical Group Inc is the incumbent with $737.3M across 100503 related awards in SCOUT’s public footprint. The current period of performance ends Mar 9, 2022.

When does Dms Pharmaceutical Group Inc’s SPE2DX22FPSZC come up for recompete?

SCOUT tracks a period-of-performance end of Mar 9, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/SPE2DX22FPSZC